Edwards Larry Todd Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$7,766.86
Insider Sells Quantity
3
Insider Sells Sum
$133,474.54

Insider Activity of Edwards Larry Todd

According to the SEC Form 4 filings, Edwards Larry Todd, being in a position of

  1. See Remarks at Arcutis Biotherapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 34870 shares for $878,096,
    over all time since 2024-05-17, has bought 1093 shares for $7,767, and sold 60363 shares for $1.21M.

Biography of Edwards Larry Todd

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $878,0963100

Comparison of Insiders on Amount of Buys and Sells

2026-03-02SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
3,687
0.0028%
$25.18$92,846+0.08%
2026-02-02SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
2,052
0.0017%
$25.50$52,323-1.35%
2025-11-06SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
29,131
0.0236%
$25.16$732,927+3.82%
2025-10-02SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
4,504
0.004%
$20.04$90,263+19.39%
2025-05-19SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
7,451
0.006%
$14.07$104,850+52.25%
2025-02-03SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
2,173
0.0018%
$12.70$27,597+24.27%
2024-11-30PurchaseArcutis Biotherapeutics, Inc.
ARQT
See Remarks
1,093
0.0005%
$7.11$7,7670%
2024-10-02SaleArcutis Biotherapeutics, Inc.
ARQT
SVP Chief Commercial Officer
3,725
0.0035%
$10.01$37,295+36.12%
2024-05-17SaleArcutis Biotherapeutics, Inc.
ARQT
SVP Chief Commercial Officer
7,640
0.0066%
$8.98$68,582+17.07%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.